(thirdQuint)Paracetamol for Cancer Pain.

 National multicenter study with an intention to include 50 patients.

 6 days treatment, 3d in each arm.

 Mean pain score last 24 h: NRS =/> 4 All drug treatment constant during the study period.

 The participants are allowed to take as much rescue opioids as necessary to have adequate relief.

 Paracetamol/ placebo given orally 1000 mg x 4 daily, three days in each arm, direct crossover.

 Daily scoring of pain relief, ESAS, overall satisfaction and rescue medication.

.

 Paracetamol for Cancer Pain@highlight

Randomised, double-blind placebo controlled cross-over trial Main goal: Optimize the medical pain treatment for patients with advanced cancer disease Study goal: Measure paracetamol's additional analgesic effect in a situation where the patient is concomitantly treated with oral opioids eqv.

 morphine > 100 mg/d.

